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OBJECTIVEdEarly pubertal onset in females is associated with increased risk for adult obe-
sity and cardiovascular disease, but whether this relationship is independent of preceding child-
hood growth events is unclear. Furthermore, the association between male puberty and adult
disease remains unknown. To clarify the link between puberty and adult health, we evaluated the
relationship between pubertal timing and risk factors for type 2 diabetes and cardiovascular
disease in both males and females from a large, prospective, and randomly ascertained birth
cohort from Northern Finland.
RESEARCH DESIGN AND METHODSdPubertal timing was estimated based on pu-
bertal height growth in 5,058 subjects (2,417 males and 2,641 females), and the relationship
between puberty and body weight, glucose and lipid homeostasis, and blood pressure at age 31
years was evaluated with linear regression modeling.
RESULTSdEarlier pubertal timing associated with higher adult BMI, fasting insulin, diastolic
blood pressure, and decreased HDL cholesterol in both sexes (P, 0.002) and with higher total
serum cholesterol, LDL cholesterol, and triglycerides in males. The association with BMI and
diastolic blood pressure remained statistically signiﬁcant in both sexes, as did the association
with insulin levels and HDL cholesterol concentrations in males after adjusting for covariates
reﬂecting both fetal and childhood growth including childhood BMI.
CONCLUSIONSdWe demonstrate independent association between earlier pubertal tim-
ing and adult metabolic syndrome-related derangements both in males and females. The con-
nection emphasizes that the mechanisms advancing puberty may also contribute to adult
metabolic disorders.
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Accumulating evidence suggests anassociation between early timing ofpuberty and adverse health outcomes
later in life. Typically evaluating females
only, these studies show that early menar-
che is correlated with increased risk for
several metabolic syndrome-associated dis-
orders in adulthood [e.g., obesity, type 2
diabetes (1,2), and cardiovascular disease
(3)]. The relationship between pubertal tim-
ing andBMI isparticularlywell-documented.
Declining ages of pubertal onset associate
with increased BMI in childhood (4–7).
Likewise, studies addressing the link be-
tween pubertal timing and later risk for
obesity show that pubertal onset is a nega-
tive predictor of adult BMI. Some studies
claim that the link between puberty and
adult BMI is a secondary consequence
of a correlation between prepubertal BMI
and puberty (6–8), but there are studies
suggesting that the association between pu-
bertal timing and adult BMI is independent
of the degree of childhood obesity (9–12).
Data on the relationship between
male pubertal timing and adult metabolic
traits are scarce. Although abnormal levels
of metabolic syndrome related-traits are
more common in males than females,
most studies exploring the relationship
between pubertal timing and risk of adult
disease have used age of menarche as the
marker of puberty. One study showed that
early pubertal timing may predict central
adiposity in adult males (9). In addition,
early puberty has been associated with ele-
vated blood pressure in two reports, al-
though the sample size was limited to
only 135 males and 148 females in one of
the studies (13,14). In contrast, early pu-
berty was not associated with increased se-
rum triglyceride levels in adult males, even
if early puberty correlated with elevated tri-
glycerides in adult females (12). Studies on
the relationship between pubertal timing
and adult glucose homeostasis in males ap-
pear to be lacking.
Because the risk for adult metabolic
disease is shaped over the life course, de-
tailed knowledge of the link with critical
developmental eventsmayhighlight impor-
tant pathogenic mechanisms. Therefore, to
disentangle the relationship between pu-
berty and cardiometabolic risk in both
sexes, we studied 2,417 males and 2,641
females of a large, unique, and genetically
homogenous birth cohort with data on
longitudinal childhood growth and a wide
spectrum of adult of cardiometabolic risk
factors. Our study had the following spe-
ciﬁc aims: 1) to assess the relationship
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between pubertal timing and adult body
size, glucose, lipids, and blood pressure,
both by evaluating the effect of pubertal
timing alone and adjusting for patterns of
prepubertal growth, and 2) to quantify the
size of the pubertal timing effect on adult
metabolic risk. Pubertal timingwas assessed
based on height growth during adolescence
using a previously validated measurement,
which allowed us to estimate the timing of
puberty similarly in both sexes.
RESEARCH DESIGN AND
METHODSdThe Northern Finland
Birth Cohort 1966 (NFBC1966) is a pro-
spective cohort study conducted in the
two northernmost provinces in Finland
(5,15,16). The study enrolled mothers
living in the district who had estimated
dates of delivery in the year 1966, includ-
ing 12,231 births representing 96% of all
births in these provinces. Data on the
mothers’ height and prepregnancy weight
were collected from standard pregnancy
follow-up forms and maternity cards car-
ried by all mothers. Growth data from the
offspring were collected at ages 6 months
and 1 year from child welfare centers and
at age 14 years by self-report from ques-
tionnaires mailed to the adolescents. Data
on age of menarche was retrospectively
obtained by a postal questionnaire at age
31 years. Roughly 3,000 individuals had
retrospectively obtained extended data on
height and weight from 1–18 years, which
had originally been collected by the pri-
mary health care service. A representative
subsample of the study participants (at
age 31 years ) was invited for clinical ex-
amination, including measurements of
height, weight, waist and hip circumfer-
ence, blood pressure, and the drawing of
fasting blood samples for the analyses of
blood glucose, serum insulin, and blood
lipids. The study design is shown in Fig. 1.
To validate the accuracy of the self-
reported data, we compared self-reported
height with the retrospectively obtained
height measurements at age 14 years.
Forty-nine percent of the study participants
(1,229 males and 1,240 females) had both
height estimates available. The agreement
between the two assessments was quite
good. Their relationship was linear, with a
Pearson correlation coefﬁcient of 0.95 vs.
0.96 in boys and girls, respectively (Sup-
plementary Fig. 1). Previous studies have
shown that adolescents often exaggerate
their self-reported height and that males
in the highest socioeconomic groups tend
to overestimate their stature more often
than males with lower socioeconomic sta-
tus (17). As expected, self-reported height
was slightly higher thanmeasured height in
our study (1.0 cm in boys and 1.1 cm in
girls), However, we could not ﬁnd any ev-
idence that the error in self-reported height
would correlate with social status (Supple-
mentary Table 1).
Fasting glucose and insulin concentra-
tions were used to calculate insulin resis-
tance index according to homeostasismodel
assessment (HOMA-IR) (18). All study sub-
jects gave their informed consent. The study
protocol in accordance with the Declaration
of Helsinki was approved by the ethical
committees of University of Oulu and the
Northern Ostrobothnia Hospital District.
Pubertal timing was assessed based on
pubertal height growth using a previously
evaluated quantitative estimate of the tim-
ing of the pubertal height growth spurt (19)
(i.e., the change in relative height between a
ﬁxed age at puberty and adulthood); in our
case, between ages 14 and 31 years. The
reason for using the difference in relative
height rather than the increase in absolute
height is that the change in relative height is
independent of ﬁnal stature. Sex steroids
are themain regulators of the pubertal spurt
in height growth, the timing of which thus
reﬂects full activation of the hypothalamic–
pituitary–gonadal axis in both sexes (20).
In practice, early-maturing individuals,
whose growth spurt occurs before age 14
years, are expected to have larger relative
height at age 14 years than they have as
adults, whereas late-maturing individuals
whose periodof fast pubertal growthoccurs
at a higher age are expected to have shorter
relative height at age 14 years than as adults.
The exact age when the adolescent height
and weight outcomes were obtained varied
between ages 13.0 and 15.0 (mean 14.3)
years. Individual estimates of height and
weight at the 14th birthday were obtained
from sex-speciﬁc regression analyses of
the growth parameters and calendar age.
Relative height (SD) at age 14 and 31 years
was calculated based on the sex-speciﬁc
population mean and standard deviation.
The current study was restricted to
5,058 study subjects with data on height
both at age 14 and 31 years. Of all study
subjects, 1,954 had complete data on all
variables reﬂecting fetal and childhood
growth. Subjects with missing data had
similar adult anthropometric or metabolic
trait values as individuals with complete
information (Supplementary Table 2).
For descriptive purposes, means and
SDs were calculated for tertiles of pubertal
timing. The relationship between pu-
bertal timing and adult, childhood, and
maternal anthropometric in addition to
adult metabolic parameters was evaluated
with linear regression modeling using R
(http://www.r-project.org/). The distribu-
tions of the mother’s BMI, adult BMI, serum
insulin, HOMA-IR, and serum triglycer-
ides were normalized by logarithmic
transformation.
RESULTSdThe descriptive analyses
showed that individuals with earlier pu-
bertal timingwere both heavier and shorter
as adults than individuals maturing later
(Table 1). Earlier developing individuals
also had more adverse lipid levels, glucose
homeostasis, and blood pressure proﬁles.
Because most of the quantiﬁed parameters
were associated with pubertal timing in a
Figure 1dStudy design. The aim of the study is to evaluate the relationship between pubertal
timing and adult anthropometric and metabolic proﬁles. The study subjects, all participants in the
Northern Finland Birth Cohort Study 1966 (NFBC1966), have been prospectively followed from
birth to adulthood and have data reﬂecting fetal, childhood, and pubertal growth, in addition to
adult anthropometric and metabolic proﬁles. FB, fasting blood. FS, fasting serum. yrs, years.
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linear fashion, we tested the signiﬁcance of
the observed patterns with linear regres-
sion analysis. We observed strong associ-
ation between adult height and pubertal
timing, which in part might represent a
spurious result of the formula used to es-
timate pubertal timing (i.e., the change in
relative height between ages 14 and 31
years). Therefore, when testing the asso-
ciation between pubertal timing and all
other adult outcomes, we adjusted the re-
gression models with adult height. Al-
most all tested parameters measured at
age 31 years showed signiﬁcant associa-
tion with pubertal timing in both sexes
(Table 2). Only adult fasting blood glu-
cose was not correlated with pubertal
timing in males, whereas serum choles-
terol and triglycerides did not correlate
with pubertal timing in females.
A signiﬁcant association between age
at puberty and adult metabolic traits does
not in itself prove a causal relationship.
Prepubertal growth events also associate
with adult metabolic outcomes. There-
fore, part or most of the observed corre-
lations might be explained by prepubertal
growth associating both with timing of
puberty and adult metabolic phenotypes.
However, our follow-up analyses showed
that pubertal timing indeed is an inde-
pendent predictor of adult metabolic risk.
Highly signiﬁcant association between
pubertal timing and BMI in addition to
waist and hip circumference was obtained
in both sexes using multivariate regres-
sion analyses, adjusting for variables re-
ﬂecting fetal and childhood growth
(Table 2). In addition, higher diastolic
blood pressure was associated indepen-
dently with earlier pubertal timing in
both sexes (P , 0.0006). Higher levels
of serum insulin and triglycerides and
lower levels of HDL cholesterol were
independently associated with earlier pu-
bertal timing only in males (P , 0.0002).
Our analyses showed that pubertal
timing inﬂuences adult metabolic out-
comes both through unique mechanisms
and mechanisms shared with preceding
events of childhood growth (Table 3). In
multivariate regression analyses, fetal,
childhood, and pubertal growth together
explained a considerable proportion of
the variation of adult anthropometric
traits (30–40% of adult BMI, 25–35% of
waist and hip circumference, and ;10%
of adult waist-to-hip ratio) in both sexes.
They explain less of the variation of adult
metabolic phenotypes (;5% of the vari-
ation in serum insulin, 1–4% of blood
pressure, and 1–1.5% of blood lipid vari-
ation). When analyzed alone, prepubertal
growth events explained 19–25% of the
adult BMI variation, whereas pubertal
timing accounted for 6 to 7%. When
Table 1dMean (SD) of anthropometric and metabolic characteristics by timing of pubertal height growth in males and females
Response variable
Timing of pubertal height growth in males Timing of pubertal height growth in females
Early
(n = 801, 33%)
Intermediate
(n = 813, 34%)
Late
(n = 803, 33%)
Early
(n = 881, 34%)
Intermediate
(n = 881, 34%)
Late
(n = 879, 33%)
Change in relative height between
age 14 years and adulthood (adult
height SDS 2 14 year height SDS) 20.46 (0.89) 0.10 (0.93) 0.46 (0.95) 20.23 (0.91) 0.00 (0.91) 0.35 (0.99)
Adult outcomes
Height (cm) 175.3 (5.7) 178.9 (6.0) 181.2 (6.0) 163.2 (5.7) 164.7 (5.7) 166.9 (6.1)
BMI (kg/m2) 26.1 (3.7) 25.4 (3.6) 24.1 (3.1) 25.5 (5.2) 23.9 (4.4) 22.9 (3.6)
Waist (cm) 90.0 (10.1) 89.6 (9.8) 87.0 (9.1) 81.1 (13.0) 78.6 (12.0) 76.6 (9.9)
Hip (cm) 97.5 (6.9) 97.9 (6.6) 97.2 (6.2) 99.2 (9.8) 96.6 (8.2) 95.8 (7.7)
FB-glucose (mmol/L) 5.2 (0.8) 5.2 (0.5) 5.2 (0.9) 5.0 (0.9) 4.9 (0.5) 4.9 (0.6)
FS-insulin (mU/mL) 9.5 (6.3) 8.9 (4.0) 8.0 (3.6) 8.8 (4.9) 8.2 (3.8) 8.1 (5.7)
HOMA-IR 2.3 (2.2) 2.1 (1.1) 1.9 (1.1) 2.0 (1.8) 1.8 (0.9) 1.8 (1.7)
Total cholesterol (mmol/L) 5.3 (1.0) 5.2 (1.0) 5.1 (1.0) 5.0 (1.0) 5.0 (1.0) 4.9 (1.0)
LDL cholesterol (mmol/L) 3.3 (0.9) 3.2 (0.9) 3.1 (0.9) 2.9 (0.8) 2.8 (0.8) 2.7 (0.8)
HDL cholesterol (mmol/L) 1.37 (0.94) 1.41 (0.33) 1.45 (0.32) 1.65 (0.39) 1.72 (0.38) 1.74 (0.39)
FS-triglycerides (mmol/L) 1.4 (0.9) 1.3 (0.9) 1.3 (0.7) 1.1 (0.6) 1.0 (0.5) 1.0 (0.6)
Systolic blood pressure (mmHg) 130.5 (13.3) 131.0 (12.7) 129.7 (12.0) 120.5 (12.7) 119.1 (11.7) 119.4 (11.7)
Diastolic blood pressure (mmHg) 81.3 (11.7) 80.9 (11.6) 78.6 (10.9) 75.3 (11.4) 74.0 (10.4) 74.2 (10.7)
Outcomes related to fetal and
childhood growth
Maternal BMI before
pregnancy (kg/m2) 23.5 (3.4) 23.4 (3.1) 23.0 (3.1) 23.4 (3.4) 23.1 (3.3) 23.0 (3.1)
Birth length (cm) 50.4 (2.0) 50.9 (2.2) 50.9 (2.3) 49.9 (2.0) 49.9 (2.0) 50.2 (2.0)
Birth weight (g) 3,479 (514) 3,589 (548) 3,617 (562) 3,408 (491) 3,419 (498) 3,502 (496)
Gestational age (weeks) 40.0 (1.9) 40.0 (1.8) 40.0 (2.0) 40.2 (1.9) 40.0 (2.0) 40.2 (1.8)
Height at age 1 year (cm) 76.3 (2.7) 76.7 (2.8) 76.9 (2.8) 75.1 (2.7) 75.1 (2.6) 75.1 (2.8)
Weight age 1 year (kg) 10.6 (1.2) 10.6 (1.1) 10.6 (1.2) 10.1 (1.2) 10.0 (1.1) 10.0 (1.2)
Mean relative height between
age 4–8 years 0.01 (0.99) 0.04 (0.99) 0.02 (0.99) 0.12 (0.92) 0.01 (0.92) 20.08 (1.01)
Mean relative BMI between
age 4–8 years 0.24 (1.00) 20.04 (0.93) 20.17 (0.81) 0.24 (1.09) 20.07 (0.91) 20.15 (0.86)
BMI at age 14 years (kg/m2) 19.9 (2.3) 19.2 (2.3) 18.2 (2.2) 20.0 (2.5) 19.3 (2.3) 18.3 (2.1)
FB, fasting blood; FS, fasting serum.
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pubertal timing was added to the regres-
sion model including prepubertal growth
variables, the proportion of explained
adult BMI variance increased only by 2
to 3%. This suggests that even if part of
the correlation between pubertal timing
and adult BMI is uniquely due to puberty,
at least half of the pubertal effect is shared
with prepubertal growth events. Quite ex-
pectedly, BMI during puberty showed
strong correlation with adult BMI. The ad-
dition of BMI at age 14 years to the regres-
sion analysis, including prepubertal
growth and pubertal timing, increased
the proportion of adult BMI variance ex-
plained with more than 10%. Pubertal
BMI also had a strong inﬂuence on adult
serum insulin levels.
Thus, early life-course events account
for a signiﬁcant proportion of the adult
metabolic trait variation. For most of the
analyzed adult traits, prepubertal growth
explained amuch greater proportion than
pubertal timing. For some variables (i.e.,
blood lipids and blood pressure), puber-
tal timing appeared to play a greater role.
In males, total cholesterol, HDL and LDL
cholesterol, and diastolic blood pressure
were inﬂuenced almost exclusively by the
timing of the pubertal growth spurt and
not by prepubertal growth.
To explore whether choosing a dif-
ferent indicator of pubertal timing would
alter the observed relationships between
puberty and adult anthropometric and
metabolic proﬁles, we reran the regres-
sion analyses substituting pubertal height
growth in females with age of menarche.
Age at menarche, which is indicative of
almost complete sexual maturation, is a
much later event in the process of female
pubertal development than the accelera-
tion of pubertal growth. The correlation
between the two manifestations of pu-
berty is 0.52 (21). Nonetheless, indexing
pubertal timing based on menarcheal age
yielded remarkably similar, highly signiﬁ-
cant associations with most of the adult an-
thropometric and metabolic traits as did
pubertal height growth (Supplementary
Tables 3 and 4).
CONCLUSIONSdOur longitudinal
population-based study provides detailed
information on factors associated with
cardiovascular risk in .5,000 children
from the genetically and environmentally
homogenous population of Northern
Finland. The results highlight that puber-
tal timing and growth are associated with
the propensity to gain weight and adverse
metabolic proﬁles in adulthood both in
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males and females. More speciﬁcally,
whereas the observed correlations in part
aremediated through preceding childhood
growth events, part of the correlation is due
to a unique pubertal timing-related effect.
In contrast to our ﬁndings, some re-
ports have challenged that pubertal timing
correlates with adult BMI independently of
childhood BMI (6–8). Because these stud-
ies have measured age of menarche in fe-
males, the discrepancy may imply that
childhoodobesitymore strongly inﬂuences
menarcheal age than the timing of the pu-
bertal growth spurt. In contrast, the previ-
ous studies adjusted their analyses for BMI
between ages 9 and 12 years (6–8) (i.e.,
during early to midpuberty), whereas we
adjusted for prepubertal BMI. Thus, the
discrepancy may be explained because the
BMI measurements in the previous studies
likely reﬂect weight changes that are asso-
ciated with sexual maturation rather than
with prepubertal growth. In support of the
latter hypothesis, our follow-up analyses of
menarcheal age indeed showed signiﬁcant
evidence for association between age of
menarche and adult BMI even if prepuber-
tal BMI was adjusted. Similar results have
been obtained from a British Birth Cohort
study (12) assessing pubertal timing based
on menarcheal age and adjusting for child-
hood BMI at age 7 years. Furthermore, a
Swedish study showed that the timing of
the pubertal growth spurt independently
predicts young adult BMI and central fat
mass in males (9). Thus, the accumulating
data together suggest that pubertal timing
indeed has an independent inﬂuence on
adult body weight.
The current study is unique in that it
provides comprehensive information on
the relationship between pubertal timing
and multiple adult metabolic traits both
in females andmales. A limited number of
studies have addressed the relationship
between pubertal timing and metabolic
outcomes in males, and previous studies
of females and males have mostly ad-
dressed rather few adult traits in addition
to providing slightly divergent correlation
patterns (12–14). The divergent results
likely reﬂect the heterogeneity of the met-
abolic phenotypes, the varying methods
used for assessing puberty, and the vary-
ing ages at which the relationship with
puberty has been assessed. Provided a sig-
niﬁcant correlation between pubertal tim-
ing and adult metabolic proﬁles exists, it
is tempting to speculate that the increase
in adult body size, insulin, and lipopro-
tein levels associated with early puberty
would affect cardiovascular morbidityT
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and risk for metabolic disease. Data in fe-
males suggest that this indeed might be the
case. Increased cardiovascular morbidity
andmortality (1–3), in addition to increased
incidence of type 2 diabetes, have been re-
ported in women with early puberty. Our
study provides strong evidence that early
pubertal timing is associated with multiple
adult metabolic derangements both in fe-
males and in males and consequently im-
plies that the puberty-associated disease risk
also applies in males.
Our study has several strengths. It is
a prospective birth cohort study of large
sample size, representing a genetically
homogenous population (22). The study
design offers the possibility of detecting
subtle differences between the groups
with varying pubertal timing. Further-
more, basing the analysis on the timing
of the pubertal spurt in height growth al-
lowed us to estimate the timing of central
onset of puberty similarly in both sexes.
However, the study has limitations. Even
though the pubertal spurt in height growth
is a characteristic of puberty in both sexes,
the current study is limited by the fact that
the growth spurt measurement described
in this article is not directly comparable be-
tween the sexes. Puberty begins on average
2 years later in boys than in girls. Because
the age of fastest pubertal growth occurs at
age 12 years in girls and age 14 years in
boys, the change in relative height between
ages 14 and 31 years provides a rather good
estimate of the timing of height growth in
males. Nonetheless, the measurement is
bound to be less informative in girls, espe-
cially its resolution to distinguish very early
puberty. However, the similar association
patterns between puberty and adult traits
obtained with menarcheal age and pubertal
growth suggest that our used growth mea-
surement, despite its limited resolution, still
quite accurately reﬂects the variation in pu-
bertal timing in girls. Nevertheless, caution
is warrantedwhen interpreting possible dif-
ferences in pubertal timing-related out-
comes between sexes in this study.
Another limitation of the current study
is that height at age 14 years is based on self-
report. Thus, wemight have underestimated
the degree of pubertal delay in somemales,
as short boys may exaggerate their self-
reported heights (23). In addition, the
error of self-reported height might be sys-
tematically correlated with potential con-
founders such as socioeconomic status
(17). Nonetheless, our veriﬁcation analyses
show that the self-reported data are quite ac-
curate. As assessed in 49% of the study par-
ticipants, there was a very close correlation
between measured and reported height
(Supplementary Fig. 1). Furthermore, so-
cial status as assessed by the occupation of
the father did not have an impact on the
accuracy of self-reported height, and in-
cluding social status in the multivariate re-
gression analyses did not change the
association between pubertal timing and
adult anthropometric and metabolic traits
(Supplementary Tables 3 and 5). Thus, the
potential impreciseness introduced by us-
ing self-reported height data at age 14 years
most likely is random, therefore causing a
dilution rather than an inﬂation of the ob-
served associations.
Multiple factors contribute to the
lifetime risk for complex, common, non-
communicable disorders, such as obesity,
type 2 diabetes, and cardiovascular dis-
ease. Our results pinpoint pubertal timing
as one such risk factor, which indepen-
dently inﬂuences several metabolic disease-
related traits, including the degree of
obesity, serum lipids, and insulin, both in
adult females and males. The observed
connection between pubertal timing and
adult metabolic outcomes implies that
mechanisms advancing puberty also may
contribute to adult metabolic disorders.
The link furthermore implies that the
detailed characterization of these mecha-
nisms potentially might help promoting
the development of more speciﬁc individ-
ual prevention strategies.
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